With Prevnar Challenger Fully Funded, Affinivax Raises $120m For Other Novel Vaccines

 
• By Mandy Jackson
  
Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background
Affinivax is developing pneumococcal and other vaccines with its MAPS platform • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business